Companies: 10,795·Total market cap: $144.5T

Clene Inc.

Clene Inc.

CLNNNASDAQHealthcare● Active

$5.33

$-0.12(-2.20%)

Market Cap$54939998

P/E Ratio—

52W High$13.5

52W Low$3.25

Avg Volume491K

Open$5.53

Beta0.92

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Clene Inc.（CLNN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CLNN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-3.25Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)134000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding9.9MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Clene Inc. 数据

分析师预测$50 · Buy

股息不分红

营收$200000-41.52%

盈利EPS $-2.65+53.26%

财务快照

FY 2025Revenue$200000.00▼ 41.52% YoY

202320242025

FY 2025Net Income-$26.2M▲ +33.57% YoY

202320242025

FY 2025EPS$-2.65▲ +53.26% YoY

202320242025

TTM:Revenue: $134000.00Net Income: -$33.5MEPS: $-3.25View income statement →

分析师评级与目标价

Buy8 位分析师

Strong Buy

0

Buy

7

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$50.00Low

$5.33Current

$50.00Avg Target上涨空间 838.09%

$50.00High

合计: 8 · 买入占比: 87.5%

根据过去 3 个月内 8 位华尔街分析师，CLNN 共识评级为 Buy，12 个月平均目标价 $50.00 （较现价 $5.33 上涨空间 838.09%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$5.33-2.20%$54.9M #2

Connect Biopharma Holdings Limited

$2.18+1.38%$137.3M #3

Context Therapeutics Inc.

$1.71-2.29%$156.7M #4

Coya Therapeutics, Inc.

$4.54+2.94%$82.7M #5

MacroGenics, Inc.

$3.86-0.77%$245.4M #6

Oramed Pharmaceuticals Inc.

$3.70-1.89%$151.2M

股票表现

1D-1.56%

1W-8.29%

1M-26.30%

3M+0.09%

YTD-8.60%

1Y+27.13%

5Y-97.69%

关于 Clene Inc.

CEORobert Etherington

IPO DateOct 18, 2018

Employees75

CountryUS

Websiteclene.com

Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nan…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Clene Inc.（CLNN）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 18, 2018 在 NASDAQ 上市。截至最近交易日，CLNN 股价为 $5.33，市值约为 $54.9M。过去12个月累计回报 +27.13%，年初至今回报 -8.60%。

根据 8 位华尔街分析师，Clene Inc. 股票共识评级为Buy，12个月平均目标价为 $50.00。2025 财年 Clene Inc. 营收 $200000.00，净利润 -$26.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Clene Inc.（CLNN）股价为 $5.33，在 NASDAQ 上市，52周区间为 $3.25 – $13.50。

CLNN 最新股价CLNN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议